Advances in markers of prodromal Parkinson disease (Q38992302)

8 September 2017

1 reference

title

Advances in markers of prodromal Parkinson disease (English)

1 reference

8 September 2017

1 reference

2

Daniela Berg

2 references

8 September 2017

ORCID Public Data File 2021

Ronald B Postuma

series ordinal

1

object named as

Ronald B Postuma

1 reference

8 September 2017

language of work or name

English

0 references

publication date

1 October 2016

1 reference

8 September 2017

published in

Nature Reviews Neurology

1 reference

8 September 2017

volume

12

1 reference

8 September 2017

issue

11

1 reference

8 September 2017

page(s)

622-634

1 reference

Toward a redefinition of Parkinson's disease

8 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.152

Changing the research criteria for the diagnosis of Parkinson's disease: obstacles and opportunities

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.152

Ageing and Parkinson's disease: substantia nigra regional selectivity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.152

Age-specific progression of nigrostriatal dysfunction in Parkinson's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.152

Staging of brain pathology related to sporadic Parkinson's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.152

Invited Article: Nervous system pathology in sporadic Parkinson disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.152

Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.152

Applicability of current staging/categorization of alpha-synuclein pathology and their clinical relevance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.152

Neuronal vulnerability, pathogenesis, and Parkinson's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.152

Neuropathological basis of nonmotor manifestations of Parkinson's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.152

Predictors of prognosis in patients with olfactory disturbance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.152

REM sleep behavior disorder in the Korean elderly population: prevalence and clinical characteristics

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.152

MDS research criteria for prodromal Parkinson's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.152

Association of olfactory dysfunction with risk for future Parkinson's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.152

The PRIPS study: screening battery for subjects at risk for Parkinson's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.152

Frequency of bowel movements and the future risk of Parkinson's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.152

Defining at-risk populations for Parkinson's disease: lessons from ongoing studies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.152

Imaging prodromal Parkinson disease: the Parkinson Associated Risk Syndrome Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.152

The prevalence of Parkinson's disease: a systematic review and meta-analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.152

Impaired olfaction and other prodromal features in the Parkinson At-Risk Syndrome Study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.152

Idiopathic hyposmia as a preclinical sign of Parkinson's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.152

Parkinson risk in idiopathic REM sleep behavior disorder: preparing for neuroprotective trials

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.152

Olfactory discrimination predicts cognitive decline among community-dwelling older adults.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.152

Risk factors for neurodegeneration in idiopathic rapid eye movement sleep behavior disorder: a multicenter study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.152

New Clinical Subtypes of Parkinson Disease and Their Longitudinal Progression: A Prospective Cohort Comparison With Other Phenotypes.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.152

Clinical significance of REM sleep behavior disorder in Parkinson's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.152

Predictors of dementia in Parkinson disease: a prospective cohort study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.152

The combined effect of REM sleep behavior disorder and hyposmia on cognition and motor phenotype in Parkinson's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.152

Rapid eye movement sleep behavior disorder: devising controlled active treatment studies for symptomatic and neuroprotective therapy--a consensus statement from the International Rapid Eye Movement Sleep Behavior Disorder Study Group.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.152

Delayed emergence of a parkinsonian disorder or dementia in 81% of older men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder: a 16-year update on a previously reported series

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.152

Neurodegenerative disorder risk in idiopathic REM sleep behavior disorder: study in 174 patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.152

Prospective outcome of rapid eye movement sleep behaviour disorder: psychiatric disorders as a potential early marker of Parkinson's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.152

Sleepiness in Idiopathic REM Sleep Behavior Disorder and Parkinson Disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.152

Probable rapid eye movement sleep behavior disorder increases risk for mild cognitive impairment and Parkinson disease: a population-based study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.152

Clinicopathologic correlations in 172 cases of rapid eye movement sleep behavior disorder with or without a coexisting neurologic disorder

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.152

Associated factors for REM sleep behavior disorder in Parkinson disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.152

A single-question screen for rapid eye movement sleep behavior disorder: a multicenter validation study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.152

Validation of the Innsbruck REM sleep behavior disorder inventory

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.152

Screening for prodromal Parkinson's disease in the general community: a sleep-based approach

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.152

How does parkinsonism start? Prodromal parkinsonism motor changes in idiopathic REM sleep behaviour disorder

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.152

Instrumented functional reach test differentiates individuals at high risk for Parkinson's disease from controls

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.152

Age, Gender, Comorbidity, and the MDS-UPDRS: Results from a Population-Based Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.152

Olfactory loss may be a first sign of idiopathic Parkinson's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.152

Hyposmia and executive dysfunction as predictors of future Parkinson's disease: a prospective study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.152

Olfaction and color vision identify impending neurodegeneration in rapid eye movement sleep behavior disorder

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.152

Olfactory dysfunction predicts early transition to a Lewy body disease in idiopathic RBD.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.152

Time to redefine PD? Introductory statement of the MDS Task Force on the definition of Parkinson's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.152

Anosmia in dementia is associated with Lewy bodies rather than Alzheimer's pathology

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.152

Identifying prodromal Parkinson's disease: pre-motor disorders in Parkinson's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.152

'Sniffin' sticks': olfactory performance assessed by the combined testing of odor identification, odor discrimination and olfactory threshold.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.152

Development of the University of Pennsylvania Smell Identification Test: a standardized microencapsulated test of olfactory function.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.152

Medical records documentation of constipation preceding Parkinson disease: A case-control study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.152

A prospective study of bowel movement frequency and risk of Parkinson's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.152

Risk of Parkinson's disease following severe constipation: a nationwide population-based cohort study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.152

Prodromal symptoms and early detection of Parkinson's disease in general practice: a nested case-control study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.152

Prediagnostic presentations of Parkinson's disease in primary care: a case-control study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.152

Meta-analysis of early nonmotor features and risk factors for Parkinson disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.152

Prodromal autonomic symptoms and signs in Parkinson's disease and dementia with Lewy bodies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.152

Alpha-synuclein in the appendiceal mucosa of neurologically intact subjects.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.152

Pathological α-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.152

Vagotomy and subsequent risk of Parkinson's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.152

Clinical implications of delayed orthostatic hypotension: A 10-year follow-up study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.152

Prevalence of orthostatic hypotension in Parkinson’s disease: A systematic review and meta-analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.152

Erectile function and risk of Parkinson's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.152

Excessive daytime sleepiness and subsequent development of Parkinson disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.152

Daytime napping, nighttime sleeping, and Parkinson disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.152

Correlates of excessive daytime sleepiness in de novo Parkinson's disease: A case control study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.152

Excessive daytime sleepiness in parkinsonism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.152

Unawareness of naps in Parkinson’s disease and in disorders with excessive daytime sleepiness

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.152

Higher incidence of depression preceding the onset of Parkinson's disease: a register study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.152

Mental health care use in Parkinson's disease: a record linkage study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.152

Depression and the subsequent risk of Parkinson's disease in the NIH-AARP Diet and Health Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.152

Depression and subsequent risk of Parkinson disease: A nationwide cohort study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.152

Prospective study of phobic anxiety and risk of Parkinson's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.152

Use of antidepressants and the risk of Parkinson's disease: a prospective study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.152

Neurodegenerative diseases target large-scale human brain networks

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.152

Anxious personality predicts an increased risk of Parkinson's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.152

What is the evidence for a premorbid parkinsonian personality: a systematic review

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.152

Restless Leg Syndrome Across the Globe: Epidemiology of the Restless Legs Syndrome/Willis-Ekbom Disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.152

Restless legs syndrome: an early clinical feature of Parkinson disease in men.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.152

Distorted color discrimination in 'de novo' parkinsonian patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.152

Color discrimination deficits in Parkinson's disease are related to cognitive impairment and white-matter alterations

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.152

Cognitive decline and quality of life in incident Parkinson's disease: The role of attention

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.152

Cognitive impairment in Parkinson's disease and dementia with Lewy bodies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.152

Cognitive performance and neuropsychiatric symptoms in early, untreated Parkinson's disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.152

MDS clinical diagnostic criteria for Parkinson's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.152

Cognition in individuals at risk for Parkinson's: Parkinson associated risk syndrome (PARS) study findings

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.152

Decreased striatal dopamine transporter uptake and substantia nigra hyperechogenicity as risk markers of synucleinopathy in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study [corrected].

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.152

Reduced striatal dopamine transporters in idiopathic rapid eye movement sleep behaviour disorder. Comparison with Parkinson's disease and controls

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.152

Measuring the rate of progression and estimating the preclinical period of Parkinson's disease with [18F]dopa PET

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.152

Rate of progression in Parkinson's disease: a 6-[18F]fluoro-L-dopa PET study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.152

The specificity and sensitivity of transcranial ultrasound in the differential diagnosis of Parkinson's disease: a prospective blinded study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.152

Postnatal decrease in substantia nigra echogenicity. Implications for the pathogenesis of Parkinson's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.152

Five-year follow-up of substantia nigra echogenicity in idiopathic REM sleep behavior disorder

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.152

Substantia nigra hyperechogenicity in healthy controls: a [¹⁸Fluoro] Dopa-PET follow-up study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.152

Altered nigrostriatal and nigrocortical functional connectivity in rapid eye movement sleep behavior disorder.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.152

White and gray matter abnormalities in idiopathic rapid eye movement sleep behavior disorder: a diffusion-tensor imaging and voxel-based morphometry study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.152

Basal ganglia dysfunction in idiopathic REM sleep behaviour disorder parallels that in early Parkinson's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.152

Reduced cardiac 123I-MIBG scintigraphy in idiopathic REM sleep behavior disorder

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.152

Abnormal metabolic network activity in REM sleep behavior disorder

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.152

Hippocampal perfusion predicts impending neurodegeneration in REM sleep behavior disorder

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.152

Heart rate variability and the risk of Parkinson disease: The Atherosclerosis Risk in Communities study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.152

Cardiovascular physiology in premotor Parkinson's disease: a neuroepidemiologic study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.152

Cardiac autonomic dysfunction in idiopathic REM sleep behavior disorder

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.152

Cardiac autonomic denervation in Parkinson's disease is linked to REM sleep behavior disorder

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.152

Pathological α-synuclein in gastrointestinal tissues from prodromal Parkinson disease patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.152

Assessment of α-synuclein in submandibular glands of patients with idiopathic rapid-eye-movement sleep behaviour disorder: a case-control study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.152

Peripheral Synucleinopathy in Early Parkinson's Disease: Submandibular Gland Needle Biopsy Findings

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.152

PREDICT-PD: identifying risk of Parkinson's disease in the community: methods and baseline results

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.152

Predicting Parkinson disease in the community using a nonmotor risk score

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.152

Diagnosis of Parkinson's disease on the basis of clinical and genetic classification: a population-based modelling study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.152

Prodromal Parkinson's disease as defined per MDS research criteria in the general elderly community

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2016.152

Violent behavior during sleep.

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27786242

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27786242

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/NRNEUROL.2016.152

1 reference

Dimensions Publication ID

8 September 2017

1027013877

0 references

1 reference